Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 14 studies | 27% ± 12% | |
| peripheral blood | 12 studies | 24% ± 10% | |
| intestine | 12 studies | 29% ± 14% | |
| kidney | 9 studies | 31% ± 10% | |
| liver | 7 studies | 36% ± 23% | |
| brain | 7 studies | 26% ± 7% | |
| eye | 6 studies | 29% ± 12% | |
| lymph node | 5 studies | 27% ± 13% | |
| bone marrow | 4 studies | 21% ± 5% | |
| uterus | 4 studies | 25% ± 13% | |
| breast | 4 studies | 26% ± 3% | |
| pancreas | 3 studies | 60% ± 16% | |
| placenta | 3 studies | 28% ± 16% | |
| adrenal gland | 3 studies | 23% ± 3% | |
| prostate | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 4996.22 | 226 / 226 | 100% | 220.22 | 406 / 406 |
| prostate | 100% | 3427.89 | 245 / 245 | 100% | 250.49 | 502 / 502 |
| brain | 100% | 2929.84 | 2639 / 2642 | 100% | 52.91 | 704 / 705 |
| kidney | 100% | 4465.75 | 89 / 89 | 100% | 102.85 | 898 / 901 |
| uterus | 100% | 1153.81 | 170 / 170 | 100% | 50.36 | 457 / 459 |
| breast | 100% | 1843.00 | 459 / 459 | 99% | 93.83 | 1111 / 1118 |
| stomach | 100% | 3681.94 | 359 / 359 | 99% | 64.09 | 284 / 286 |
| thymus | 99% | 1281.93 | 649 / 653 | 100% | 52.05 | 602 / 605 |
| intestine | 100% | 2414.61 | 966 / 966 | 98% | 68.51 | 518 / 527 |
| adrenal gland | 100% | 3143.96 | 258 / 258 | 98% | 59.70 | 226 / 230 |
| ovary | 100% | 1195.27 | 180 / 180 | 98% | 36.44 | 422 / 430 |
| lung | 99% | 1322.56 | 572 / 578 | 99% | 49.15 | 1141 / 1155 |
| bladder | 100% | 1578.33 | 21 / 21 | 98% | 54.51 | 492 / 504 |
| pancreas | 97% | 1046.74 | 319 / 328 | 99% | 49.75 | 176 / 178 |
| esophagus | 100% | 1787.01 | 1445 / 1445 | 95% | 38.07 | 173 / 183 |
| skin | 99% | 1342.13 | 1792 / 1809 | 90% | 27.79 | 424 / 472 |
| adipose | 100% | 1831.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 51.31 | 29 / 29 |
| muscle | 100% | 3624.82 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 66.79 | 1 / 1 |
| blood vessel | 100% | 1817.09 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 99% | 999.17 | 239 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 3630.06 | 847 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 35.54 | 44 / 45 |
| peripheral blood | 77% | 1002.93 | 715 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 45% | 9.66 | 36 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006850 | Biological process | mitochondrial pyruvate transmembrane transport |
| GO_0006086 | Biological process | acetyl-CoA biosynthetic process from pyruvate |
| GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO_0098800 | Cellular component | inner mitochondrial membrane protein complex |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0050833 | Molecular function | pyruvate transmembrane transporter activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MPC2 |
| Protein name | Mitochondrial pyruvate carrier 2 (Brain protein 44) Mitochondrial pyruvate carrier |
| Synonyms | BRP44 |
| Description | FUNCTION: Mediates the uptake of pyruvate into mitochondria. . FUNCTION: Mediates the uptake of pyruvate into mitochondria. . |
| Accessions | ENST00000458574.1 Q5R3B4 ENST00000367846.8 O95563 ENST00000271373.9 |